No evidence of oxidant events in amphotericin B cytotoxicity versus L-infantum promastigotes

被引:7
作者
Azas, N [1 ]
Di Giorgio, C [1 ]
Delmas, F [1 ]
Gasquet, M [1 ]
Timon-David, P [1 ]
机构
[1] Fac Pharm Marseille, Parasitol Lab, F-13385 Marseille 05, France
关键词
Leishmania infantum; membrane potential; antibiotic susceptibility; membrane permeability; amphotericin B; ketoconazole; ascorbic acid; catalase;
D O I
10.1051/parasite/2001084335
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学]; 100103 [病原生物学];
摘要
Amphotericin B is used for the treatment of systemic mycoses and visceral leishmaniasis. The objective of our study was to evaluate the impact of catalase, ascorbic acid and ketoconazole on the amphotericin B toxicity towards Leishmania promastigotes membrane by two flow cytometric tests, the membrane potential assay using a cationic dye, [DiOC(5) (3)], and the membrane permeability test using propidium iodide, The collapse of membrane potential appeared at amphotericin B concentrations weaker than those assessed by the membrane permeability test. The binding of amphotericin B to membrane sterol was net modified by catolase or ascorbic acid whereas amphotericin B-induced growth inhibition could be modulated by these products. The permeabilizing effect of amphotericin B on parasite membrane was strongly reduced in the presence of ketoconazole These results confirmed the pore hypothesis of amphotericin B action and suggested that flow cytometric methods constituted a valuable alternative to conventional methods for assessing the effect of drugs on cellular membrane and evaluating parasite susceptibility to polyene antibiotics.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 24 条
[1]
Leishmania infantum promastigotes: Flow cytometry as a possible tool for assessing the effects of drugs on cellular functions [J].
Azas, N ;
DiGiorgio, C ;
Delmas, F ;
Gasquet, M ;
TimonDavid, P .
EXPERIMENTAL PARASITOLOGY, 1997, 87 (01) :1-7
[2]
Azas N, 1997, CYTOMETRY, V28, P165, DOI 10.1002/(SICI)1097-0320(19970601)28:2&lt
[3]
165::AID-CYTO10&gt
[4]
3.0.CO
[5]
2-O
[7]
BEGGS WH, 1979, FEMS MICROBIOL LETT, V6, P409, DOI 10.1111/j.1574-6968.1979.tb03753.x
[8]
BERMAN JD, 1988, REV INFECT DIS, V10, P560
[9]
AMPHOTERICIN-B - CURRENT UNDERSTANDING OF MECHANISMS OF ACTION [J].
BRAJTBURG, J ;
POWDERLY, WG ;
KOBAYASHI, GS ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :183-188
[10]
LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF VISCERAL LEISHMANIASIS [J].
CROFT, SL ;
DAVIDSON, RN ;
THORNTON, EA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :111-118